美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Immunovant, Inc.

30.28

+0.0000

成交量：- -

成交额：- -

市值：19.08亿

市盈率：-34.37

高：30.28

开：30.28

低：30.28

收：30.28

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

Immunovant, Inc.

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

- -

邮编：

- -

电话：

- -

传真：

- -

简介：

Immunovant, Inc.于2018年12月6日在特拉华州注册成立。该公司成立的目的是与一家或多家企业进行合并，股份交换，资产收购，股票购买，资本重组，重组或类似业务合并。虽然对其目标所在的行业没有任何限制或限制，但他们打算追求专注于医疗保健创新的未来目标。该公司预计将定位于北美或欧洲的公司，这些公司正在开发生物制药和医疗资产。技术部门，与管理团队在医疗保健投资和药物开发方面的经验相一致。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/IMVTU/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMVTU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMVTU\",,,,,undefined,":{"symbol":"IMVTU","market":"US","secType":"STK","nameCN":"Immunovant, Inc.","latestPrice":30.277,"timestamp":1591991968314,"preClose":30.277,"halted":3,"volume":0,"delay":0,"floatShares":11447972,"shares":63014824,"eps":-0.881038,"marketStatus":"停牌","change":0,"latestTime":"06-12 15:59:28 EDT","open":30.277,"high":30.277,"low":30.277,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.881038,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1743580800000},"marketStatusCode":5,"adr":0,"listingDate":1557460800000,"exchange":"NASDAQ","adjPreClose":30.277,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMVTU\",,,,,undefined,":{"symbol":"IMVTU","floatShares":11447972,"roa":"--","roe":"--","lyrEps":-0.630873,"shares":63014824,"dividePrice":0,"high":30.277,"amplitude":0,"preClose":30.277,"low":30.277,"week52Low":10.3174,"pbRate":"17.06","week52High":33.3,"institutionHeld":0,"latestPrice":30.277,"eps":-0.881038,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.881038,"open":30.277,"prevYearClose":24.5},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0256},{"period":"1month","weight":-0.0586},{"period":"3month","weight":-0.0455},{"period":"6month","weight":-0.0166},{"period":"1year","weight":0.0694},{"period":"ytd","weight":-0.0455}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Immunovant, Inc.于2018年12月6日在特拉华州注册成立。该公司成立的目的是与一家或多家企业进行合并，股份交换，资产收购，股票购买，资本重组，重组或类似业务合并。 虽然对其目标所在的行业没有任何限制或限制，但他们打算追求专注于医疗保健创新的未来目标。该公司预计将定位于北美或欧洲的公司，这些公司正在开发生物制药和医疗资产。 技术部门，与管理团队在医疗保健投资和药物开发方面的经验相一致。","exchange":"NASDAQ","name":"Immunovant, Inc.","nameEN":"Immunovant, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"IMVTU\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMVTU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMVTU\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IMVTU\",market:\"US\",delay:false,,,undefined,":{}}}